Aaron Martin
Managing Partner @ Allumia Ventures
Seattle, United States
Aaron Martin is a venture - series unknown investor at Allumia Ventures in Seattle focused on Health Care and Hospital. Aaron Martin is Executive Vice President, Chief Digital Officer at Providence St. Joseph Health.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Aaron Martin invests in
Stages Aaron Martin invests in
Countries Aaron Martin invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (67%)
- Hospital 2 (33%)
- Information Technology 2 (33%)
- Medical 1 (17%)
- Software 1 (17%)
Stage
- Venture - Series Unknown 2 (33%)
- Series A 1 (17%)
- Series B 1 (17%)
- Funding Round 1 (17%)
- Corporate Round 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Xealth is a platform for digital health that enables health systems to easily organize, integrate, deploy and activate digital health tools from within the EHR workflow. Through the secure Xealth platform, clinicians can find and order the right digital tools and programs for patients direct from the EHR workflow, send these digital health ordersto the patient’s smartphone or desktop, and then monitor patient engagement and analyze the effects of more engaged patients. Xealth enables healthcare teams to order digital content and services as easily as they do medications today. The patients can then access these digital health prescriptions from the provider's portal so that they can actively manage their health. It spun out of Providence St. Joseph Health (PSJH) in 2017, and investors include McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC, and the Froedtert and Medical College of Wisconsin Health Network. | $25M / Series B / Oct 05, 2021 | ||
| RxRevu is a physician-founded organization on a mission to become the leader in prescription decision support, helping prescribers identify the most cost-effective medications for each patient, at the point of care. RxRevu was referred to as the “Google of Drugs” by CNBC and is currently working with health systems, PBMs, and electronic healthrecords (EHR) vendors.RxRevu’s EHR-embedded technology allows prescribers to view prior authorizations and real-time, patient-specific cost and drug options aligned with formulary and benefit data. This information is provided directly from the payer/PBM to inform the prescriber before medication selection. In addition, the platform provides prescription health analytics to help organizations understand prescribing behavior and drive consistent prescribing practices in line with an organization's best practices. | $8M / Jun 28, 2021 | ||
| Twistle is a health care platform that helps healthcare providers connect with patients, keeping them on track for faster recovery. Its "Care Plan Automation" platform helps clinical teams streamline care pathways by automating follow-up and surveillance. Its mobile health tool connects providers and patients through secure automatedmessaging, photo/lab sharing, surveys, smart device/EHR integration, and more.The company was founded in 2011 and is headquartered in Seattle, Washington. | $18M / Venture - Series Unknown / Feb 03, 2020 | ||
| Xealth is a platform for digital health that enables health systems to easily organize, integrate, deploy and activate digital health tools from within the EHR workflow. Through the secure Xealth platform, clinicians can find and order the right digital tools and programs for patients direct from the EHR workflow, send these digital health ordersto the patient’s smartphone or desktop, and then monitor patient engagement and analyze the effects of more engaged patients. Xealth enables healthcare teams to order digital content and services as easily as they do medications today. The patients can then access these digital health prescriptions from the provider's portal so that they can actively manage their health. It spun out of Providence St. Joseph Health (PSJH) in 2017, and investors include McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC, and the Froedtert and Medical College of Wisconsin Health Network. | $11M / Series A / Mar 27, 2019 | ||
| Kyruus delivers proven provider search and scheduling solutions that help hospitals and health systems match patients with the providers best suited to care for them. The ProviderMatch suite of solutions—for consumers, access centers, and referral networks—enables a consistent patient experience across multiple points of access, while aligningprovider supply with patient demand. The company’s proprietary provider data management platform forms the foundation of its solutions, powering them with accurate data by coupling data processing with administrative applications.Kyruus was founded in 2010 and is headquartered in Boston, Massachusetts. | $10M / Corporate Round / Apr 18, 2018 | ||
| See all 6 investments → | |||
Co-Investors
About Allumia Ventures
Providence Ventures generally targets mid- to late-stage venture investments across Healthcare IT, MedTech, and tech-enabled services.
Allumia Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Daniel Galles
Partner
|
|||
Jeffery Stolte
Senior Partner
|
|||
|
Aaron Martin
Managing Partner
|
|||
Branden Fini
Senior Associate
|
|||
Cyril Philip
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Aaron Martin invest in?
Aaron Martin invests primarily in Health Care, Hospital and Information Technology startups, most often at Venture - Series Unknown and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Aaron Martin?
Public channels for Aaron Martin include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Aaron Martin last invest?
The most recent investment recorded for Aaron Martin closed in Sep 2021. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
